314930 Stock Chart & Stats
₩7380.00
-₩70.00(-0.94%)
―
--
Day’s Range― - ―
52-Week Range₩6,600.00 - ₩16,860.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)48.31K
Market Cap
₩219.60B
Enterprise Value₩250.54K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)177.9
Beta0.34
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.96
Shares Outstanding29,764,103
10 Day Avg. Volume43,070
30 Day Avg. Volume48,315
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
314930 FAQ
What was BIODYNE Co., Ltd.’s price range in the past 12 months?
BIODYNE Co., Ltd. lowest stock price was ₩6600.00 and its highest was ₩16860.00 in the past 12 months.
What is BIODYNE Co., Ltd.’s market cap?
BIODYNE Co., Ltd.’s market cap is ₩219.60B.
When is BIODYNE Co., Ltd.’s upcoming earnings report date?
BIODYNE Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 89 days.
How were BIODYNE Co., Ltd.’s earnings last quarter?
BIODYNE Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩10.959 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is BIODYNE Co., Ltd. overvalued?
According to Wall Street analysts BIODYNE Co., Ltd.’s price is currently Undervalued.
Does BIODYNE Co., Ltd. pay dividends?
BIODYNE Co., Ltd. does not currently pay dividends.
What is BIODYNE Co., Ltd.’s EPS estimate?
BIODYNE Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIODYNE Co., Ltd. have?
BIODYNE Co., Ltd. has 29,764,103 shares outstanding.
What happened to BIODYNE Co., Ltd.’s price movement after its last earnings report?
BIODYNE Co., Ltd. reported an EPS of -₩10.959 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.79%.
Which hedge fund is a major shareholder of BIODYNE Co., Ltd.?
Currently, no hedge funds are holding shares in KR:314930
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kolon Life Science Inc.
―
HUMEDIX Co.LTD.
―
Boditech Med, Inc.
―
PROTEINA Co., Ltd.
―
IMBiologics Corp.
―